| Health / Medical Topics |
PEP-3-KLH Conjugate Vaccine
A cancer vaccine consisting of PEP-3, a synthetic peptide encompassing a tumor-specific mutated segment of the epidermal growth factor receptor type vIII (EGFRvIII), conjugated to the naturally-occuring immunoadjuvant keyhole limpet hemocyanin (KLH) with potential immunostimulating and antineoplastic activities. Upon administration, PEP-3-KLH conjugate vaccine may induce a cytotoxic immune response against tumor cells that overexpress EGFRvIII; this antitumoral immune response may involve antibody-dependent cellular cytotoxicity (ADCC). (NCI Thesaurus)
YOU MAY ALSO LIKE
Human beings in general.
An anthocyanidin with hydroxyl groups at C-3, -5, -7, and -4', and a methoxyl group at C-3'.
The substitution of missing data with the next-to-last value that is not missing.
A drug used to prevent blood clotting and as a treatment that may help decrease weight loss in people with cancer. …
The active ingredient in a drug that is used to treat hairy cell leukemia and is being studied in the treatment of…
The pentose phosphate pathway is a process of glucose turnover that produces NADPH as reducing equivalents and pentoses as essential parts of…
